Experimental medicine for insulin-treated type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had type 2 diabetes for at least 5 years.
- Your body mass index (BMI) is between 18 and 30 (check with your doctor).
- Your most recent A1c test result is between 7.0% and 10.0%.
- You are currently using insulin every day and are considered insulin-dependent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called RGB-5088 in people with type 1 diabetes. It aims to see if the treatment is safe and if it helps control blood sugar.
This study tests an investigational medicine called GZR101-80 for people with type 2 diabetes. It aims to see how well it controls blood sugar and how safe it is.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.